Opus Genetics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $755 | $2,157 | $3,865 | $3,079 |
Gross Profit | 755 | 2,144 | 3,865 | 3,079 |
EBITDA | -7,567 | -64,871 | -15,112 | -17,373 |
EBIT | -64,884 | -15,125 | -17,386 | |
Net Income | -8,098 | -65,535 | -16,523 | -17,454 |
Net Change In Cash | 755 | 2,157 | 3,865 | 3,079 |
Free Cash Flow | -11,950 | -12,727 | -9,833 | -6,157 |
Cash | 88,812 | 59,959 | 45,091 | 30,815 |
Basic Shares | 111,384 | 868,913 | 622,219 | 70,636 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $14,196 | $10,992 | $19,049 | $39,850 |
Gross Profit | 14,196 | 10,992 | 19,049 | 39,850 |
EBITDA | -48,072 | -57,522 | -9,968 | 18,216 |
EBIT | -48,125 | -57,532 | -9,974 | 18,212 |
Net Income | -49,591 | -57,532 | -9,986 | 17,888 |
Net Change In Cash | 14,196 | 10,992 | 19,049 | 39,850 |
Free Cash Flow | -35,253 | -25,576 | -1,112 | 14,314 |
Cash | 45,091 | 30,321 | 50,501 | 42,634 |
Basic Shares | 622,219 | 26,715 | 21,589 | 20,597 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.14 |
2026-03-31 | -$0.75 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.25 |